According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today ...

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024.

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.38 ...

Senores Pharmaceuticals IPO sees high demand; allocation on Dec 26, GMP suggests strong listing. Stay informed!

Analysts have recommended investors subscribe to the issue, citing attractive valuations and strong demand for ...

The ongoing offers are expected to list at a premium of as much as 80% over the IPO price. Check their latest grey market ...

The Senores Pharmaceuticals' public issue will close for public bidding on Tuesday, December 24. The IPO has received 13.93x ...

From opening to allotment and listing, here is the complete list of IPO activities set to keep the D-Street investors busy ...

Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India.

Senores Pharmaceuticals IPO sees robust demand, with potential listing gain of 59%, scheduled to list on BSE and NSE.

The grey market premium of Senores Pharmaceuticals IPO was Rs 240 as of 05:04 a.m. on Dec. 26, indicating a strong gain of 61 ...

Investors can check their allotment status through multiple platforms such as NSE, BSE and also through the registrar’s ...